Pigmentation Clinical Trial
Official title:
Evaluation of the Dermal Cooling System for the Enhanced Treatment of Benign Pigmented Lesions and Common Skin Conditions
NCT number | NCT04493021 |
Other study ID # | R2-20-001 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | July 7, 2020 |
Est. completion date | May 31, 2022 |
Verified date | August 2023 |
Source | R2 Dermatology |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to evaluate the Dermal Cooling System for lightening of benign pigmented lesions and to assess additional cosmetic benefits.
Status | Completed |
Enrollment | 137 |
Est. completion date | May 31, 2022 |
Est. primary completion date | May 31, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: 1. Male or female subjects > 18 years of age. 2. Subject has one or more benign pigmented lesions (e.g., solar lentigines, freckles, seborrheic keratosis), in an area suitable for treatment. 3. Subject is willing to have up to 40 treatment sites treated per treatment session depending on the size and nature of the lesions identified. 4. Subject is willing to have digital photographs taken of the treatment area and agrees to use of photographs for presentation, educational, or marketing purposes. 5. Subject is willing to cover treated area or have very limited sun exposure and use an approved sunscreen of SPF 50 or higher on the treated area for the duration of the study, including the follow-up period, if requested. 6. Subject has read and signed a written informed consent form. 7. Subject is willing to comply with adjuvant topical regimen, as applicable. - Exclusion Criteria: 1. Physician prescribed medical or surgical treatment, or use of over-the-counter products to alter skin color, in the area of intended treatment in the previous 6 months (e.g., hydroquinone, corticosteroids, laser surgery) 2. Use of products containing glycolic acids, retinol, salicylic acid within the previous 2 weeks 3. Use of Accutane within the previous 6 months 4. Artificial tanning in the area of intended treatment within 1 month (e.g., spray, lotion, tanning bed) or intention to use artificial tanning within the follow-up period 5. Scars or tattoos in the location of the treatment sites 6. History of melasma, vitiligo, eczema, or psoriasis in the area of treatment 7. History of melanoma 8. Subject is pregnant or intending to become pregnant during the study period 9. Subject is lactating or has been lactating in the past 6 months 10. Known history of illness or adverse reaction to cold insult (e.g., cryoglobulinemia, cold urticaria, paroxysmal cold hemoglobinuria, Reynaud's disease. 11. History of abnormal wound healing or abnormal scarring 12. Inability or unwillingness to comply with the study requirements. 13. Current enrollment in a clinical study of any other unapproved investigational drug or device. 14. Any other condition or laboratory value that would, in the professional opinion of the investigator, potentially affect response or participation in this clinical study, or would pose an unacceptable risk to the subject. - |
Country | Name | City | State |
---|---|---|---|
United States | Sculptology | Pleasanton | California |
Lead Sponsor | Collaborator |
---|---|
R2 Dermatology |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Improvement in the appearance of the treated areas as assessed by Investigator assessment. | Investigator assessment using Global Aesthetic Improvement Scale (GAIS); graded from "4" (very much improved") to "0" (worse). | 2-Month Follow-up visit | |
Primary | Safety of the treatment | Determined by incidence of device-or procedure-related adverse events | Up to 12 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05913102 -
A Prospective, Split-face, Randomized Study of the Poly-D, L Lactic Acid (PDLLA) for Photoaged Skin
|
N/A | |
Recruiting |
NCT04539561 -
Evaluation of the Efficacy and Safety of PiQo4 for the Treatment of Hand Pigmentation Using 1064nm PSL and 532nm PSL
|
N/A | |
Completed |
NCT05750914 -
Evaluation of Broadband Light Treatment for Pigmented Skin Lesions
|
N/A | |
Recruiting |
NCT06074276 -
The Effects of Almond on Facial Skin Collagen and Wrinkles
|
N/A | |
Completed |
NCT05662592 -
Evaluation of Broadband Light Treatment Protocol for Pigmented Skin Lesions - A Comparative Study
|
N/A | |
Recruiting |
NCT05847530 -
Pilot Evaluation of the Cynosure Potenza™ System for Treatment of Cosmetic Dermatologic Skin Conditions
|
N/A | |
Enrolling by invitation |
NCT01847066 -
Epidermal Delivery of Ani-Aging Ingredients
|
N/A | |
Completed |
NCT03065582 -
The Effect of Topical Sunscreen Plus Antioxidant Against the Visible Light Biological Effects
|
N/A | |
Completed |
NCT03565146 -
Evaluation of the Efficacy and Safety of PiQo4 System for the Treatment of Pigmented Lesions
|
N/A | |
Terminated |
NCT02506101 -
Randomized, Split-body, Single-blinded Clinical Trial of NB-UVB Treatment for Vitiligo
|
N/A | |
Not yet recruiting |
NCT05160103 -
16-Week Randomized Split-Face Efficacy Study of Cosmetic Formulations in Photoaged Pigmented Skin Subjects
|
N/A | |
Completed |
NCT06075641 -
Post Gingival Depigmentation Assessment: Comparison of Surgical Stripping vs (Er,Cr:YSGG) Laser
|
N/A | |
Completed |
NCT01885091 -
Efficacy and Safety Study of Kinerase® for Treatment of Cutaneous Facial Photodamage
|
Phase 4 | |
Completed |
NCT05710068 -
Effects of RF Microneedle on Photoaging Skin
|
N/A | |
Completed |
NCT05304624 -
Comparison of Er,Cr:YSGG Laser and Diode Laser in the Treatment of Gingival Melanin Pigmentation
|
N/A | |
Recruiting |
NCT04866797 -
Photoprotection Efficacy With Sunscreen Formulas Containing the Cyclic Merocyanine Long-UVA Absorber MCE Under UV Day Light Exposure
|
N/A | |
Recruiting |
NCT04865094 -
Photoprotection Efficacy With Sunscreen Formulas Containing the Cyclic Merocyanine Long-UVA Absorber MCE Under Long-UVA Exposure
|
N/A | |
Completed |
NCT04881058 -
Post Market Clinical Follow Up Study to Collect Additional Data and Imaging
|
N/A | |
Completed |
NCT03970317 -
Safety and Efficacy of Broad Band Light In Motion Treatment
|
N/A |